James P. McGettigan, PhD

James P. McGettigan, PhD

Contact Dr. McGettigan

1020 Locust Street
Jefferson Alumni Hall
Room 466
Philadelphia, PA 19107

(215) 503-4629
(215) 923-7144 fax

Most Recent Peer-reviewed Publications

  1. APRIL:TACI axis is dispensable for the immune response to rabies vaccination
  2. Targeting vaccine-induced extrafollicular pathway of B cell differentiation improves rabies postexposure prophylaxis
  3. Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination
  4. A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses
  5. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs
  6. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells In Vitro and enhanced antibody titers In-Vivo
  7. Reinvestigating the role of igM in rabies virus postexposure vaccination
  8. B cell infection and activation by rabies virus-based vaccines
  9. Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses
  10. Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity
  11. Experimental rabies vaccines for humans
  12. Characterization of a single-cycle rabies virus-based vaccine vector
  13. The cell biology of rabies virus: Using stealth to reach the brain
  14. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251challenge
  15. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates
  16. Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity
  17. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
  18. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway
  19. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6PEnv and simian immunodeficiency virusmac239Gag are safe in rhesus macaques and protect from an AIDS-like disease
  20. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice